The plasma membrane calcium ATPase and disease

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Plasma membrane calcium ATPase (PMCA) proteins actively transport calcium ions (Ca2+) out of the cell, maintaining low intracellular Ca2+ concentrations.
• Four mammalian genes (ATP2B1-ATP2B4) encode PMCA proteins, which are subject to alternative splicing and post-translational modifications, generating diverse functional variants.
• While generally redundant, specific PMCA isoforms play critical roles in vital tissues.

Purpose of the Study:

• To investigate the physiological roles and disease relevance of different PMCA isoforms.
• To explore the link between PMCA gene mutations and specific human and mammalian diseases.
• To understand how altered PMCA expression impacts complex health conditions.

Main Methods:

• Analysis of naturally occurring mutations in PMCA genes in mouse models.
• Investigation of targeted null mutations in specific PMCA genes (Atp2b1, Atp2b4).
• Correlation of PMCA expression changes with various disease pathologies.

Main Results:

• Mutations in the Atp2b2 gene are causally linked to deafness and ataxia in mice.
• A specific PMCA2 missense mutation in humans affects the severity of hearing loss.
• Null mutations in Atp2b1 and Atp2b4 lead to embryonic lethality and sperm motility defects, respectively.
• Altered PMCA expression is associated with conditions such as cataracts, cancer, diabetes, hypertension, and cardiac hypertrophy.

Conclusions:

• PMCA isoforms are crucial for maintaining cellular calcium homeostasis and have distinct physiological roles.
• Dysregulation of PMCA function through mutations or altered expression contributes to a spectrum of human diseases.
• Further research into PMCA isoforms may reveal therapeutic targets for complex conditions like hearing loss, infertility, and cardiovascular diseases.